O-2545
In today's world, O-2545 has become a topic of great relevance and interest to a wide audience. With the constant growth of technology and globalization, O-2545 has gained unprecedented importance in our daily lives. Whether we are talking about O-2545 in the field of health, politics, culture or any other aspect of society, its impact is undeniable. In this article, we will explore the topic of O-2545 in depth, examining its implications, challenges and opportunities in today's world. From its origins to its future projections, O-2545 is a topic that deserves to be explored in depth to better understand its influence on our lives.
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C26H36N2O2 |
| Molar mass | 408.586 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
O-2545 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. Unlike most cannabinoids discovered to date, it is water-soluble, which gives it considerable advantages over many related cannabinoids. It has high affinity for both CB1 and CB2 receptors, with Ki values of 1.5 nM at CB1 and 0.32 nM at CB2.
See also
References
- ^ Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK (September 2006). "Pharmacological characterization of novel water-soluble cannabinoids". The Journal of Pharmacology and Experimental Therapeutics. 318 (3): 1230–9. doi:10.1124/jpet.106.104109. PMID 16757541. S2CID 14864925.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |